Literature DB >> 17286152

Olanzapine overdose is associated with acute muscle toxicity.

W S Waring1, J Wrate, D N Bateman.   

Abstract

Olanzapine is an atypical antipsychotic that is reported to cause myopathy and raised creatine kinase (CK) levels. The prevalence and severity of acute myopathy after deliberate olanzapine ingestion are unclear. Therefore, we reviewed case notes from 64 consecutive patients admitted to our institution after olanzapine overdose. Overall, serum CK was higher than five times the upper limit of normal in 17% of patients. The prevalence of raised CK values was positively correlated with the stated quantity of olanzapine ingested, suggesting a dose-dependent relationship for acute muscle toxicity. There was an apparent delay of 12 hours or more between olanzapine ingestion and the occurrence of maximum CK. Despite the high prevalence of acute muscle toxicity after olanzapine ingestion, none of the patients developed renal failure.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17286152     DOI: 10.1177/0960327106073832

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  9 in total

Review 1.  Overdose of atypical antipsychotics: clinical presentation, mechanisms of toxicity and management.

Authors:  Michael Levine; Anne-Michelle Ruha
Journal:  CNS Drugs       Date:  2012-07-01       Impact factor: 5.749

2.  Doxylamine toxicity: seizure, rhabdomyolysis and false positive urine drug screen for methadone.

Authors:  Husnain Syed; Sumit Som; Nazia Khan; Wael Faltas
Journal:  BMJ Case Rep       Date:  2009-03-17

3.  Acute camptocormia induced by olanzapine: a case report.

Authors:  Florence Robert; Martial Koenig; Aurélie Robert; Stéphane Boyer; Pascal Cathébras; Jean-Philippe Camdessanché
Journal:  J Med Case Rep       Date:  2010-06-25

Review 4.  A systematic review of cardiovascular effects after atypical antipsychotic medication overdose.

Authors:  Hock Heng Tan; Jason Hoppe; Kennon Heard
Journal:  Am J Emerg Med       Date:  2009-06       Impact factor: 2.469

Review 5.  Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.

Authors:  Beatrice A Golomb; Marcella A Evans
Journal:  Am J Cardiovasc Drugs       Date:  2008       Impact factor: 3.571

6.  Renal failure prevalence in poisoned patients.

Authors:  Mohammad Arefi; Fakhroddin Taghaddosinejad; Peyman Salamaty; Davood Soroosh; Hami Ashraf; Mohsen Ebrahimi
Journal:  Nephrourol Mon       Date:  2014-03-11

7.  Olanzapine overdose presenting with acute muscle toxicity.

Authors:  Niraj Keyal; Gentle Sunder Shrestha; Saurabh Pradhan; Ramesh Maharjan; Subhash Prasad Acharya; Moda Nath Marhatta
Journal:  Int J Crit Illn Inj Sci       Date:  2017 Jan-Mar

8.  Samidorphan mitigates olanzapine-induced weight gain and metabolic dysfunction in rats and non-human primates.

Authors:  Jacobi I Cunningham; David J Eyerman; Mark S Todtenkopf; Reginald L Dean; Daniel R Deaver; Connie Sanchez; Mark Namchuk
Journal:  J Psychopharmacol       Date:  2019-07-11       Impact factor: 4.153

Review 9.  Rhabdomyolysis associated with fibrate therapy: review of 76 published cases and a new case report.

Authors:  Jianyong Wu; Yan Song; Heng Li; Jianghua Chen
Journal:  Eur J Clin Pharmacol       Date:  2009-09-16       Impact factor: 3.064

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.